CN112544968A - Whitening and freckle removing composition and preparation method thereof - Google Patents
Whitening and freckle removing composition and preparation method thereof Download PDFInfo
- Publication number
- CN112544968A CN112544968A CN202011399632.1A CN202011399632A CN112544968A CN 112544968 A CN112544968 A CN 112544968A CN 202011399632 A CN202011399632 A CN 202011399632A CN 112544968 A CN112544968 A CN 112544968A
- Authority
- CN
- China
- Prior art keywords
- extract
- yeast
- whitening
- yeast extract
- removing composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 230000002087 whitening effect Effects 0.000 title claims abstract description 36
- 208000003351 Melanosis Diseases 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title abstract description 7
- 239000012138 yeast extract Substances 0.000 claims abstract description 54
- 229940041514 candida albicans extract Drugs 0.000 claims abstract description 53
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims abstract description 28
- 235000013793 astaxanthin Nutrition 0.000 claims abstract description 28
- 239000001168 astaxanthin Substances 0.000 claims abstract description 28
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims abstract description 28
- 229940022405 astaxanthin Drugs 0.000 claims abstract description 28
- 239000000284 extract Substances 0.000 claims abstract description 22
- 238000005303 weighing Methods 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 6
- 239000000843 powder Substances 0.000 claims description 26
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 23
- 241000168517 Haematococcus lacustris Species 0.000 claims description 22
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 20
- 108010024636 Glutathione Proteins 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 229960003180 glutathione Drugs 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 7
- 108090000526 Papain Proteins 0.000 claims description 6
- 239000004365 Protease Substances 0.000 claims description 6
- 229940055729 papain Drugs 0.000 claims description 6
- 235000019834 papain Nutrition 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 3
- 230000000415 inactivating effect Effects 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 238000000855 fermentation Methods 0.000 claims description 2
- 230000004151 fermentation Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 235000013305 food Nutrition 0.000 abstract description 8
- 239000002994 raw material Substances 0.000 abstract description 4
- 102000003425 Tyrosinase Human genes 0.000 abstract description 3
- 108060008724 Tyrosinase Proteins 0.000 abstract description 3
- 206010014970 Ephelides Diseases 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 235000013373 food additive Nutrition 0.000 abstract description 2
- 239000002778 food additive Substances 0.000 abstract description 2
- 235000013402 health food Nutrition 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 12
- 239000002775 capsule Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 238000007873 sieving Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- KZEVSDGEBAJOTK-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[5-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]ethanone Chemical group N1N=NC=2CN(CCC=21)C(CC=1OC(=NN=1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O KZEVSDGEBAJOTK-UHFFFAOYSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical group C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- JQMFQLVAJGZSQS-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical group C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JQMFQLVAJGZSQS-UHFFFAOYSA-N 0.000 description 1
- JVKRKMWZYMKVTQ-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical group C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JVKRKMWZYMKVTQ-UHFFFAOYSA-N 0.000 description 1
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical group N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000169546 Lycium ruthenicum Species 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- -1 etc. Chemical compound 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 230000036564 melanin content Effects 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000007427 paired t-test Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009979 protective mechanism Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
- A23L31/10—Yeasts or derivatives thereof
- A23L31/15—Extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
- A23L33/145—Extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a whitening and freckle-removing composition, which is used in the field of food or health-care food and can lighten the skin to achieve the effects of whitening and removing freckles. The whitening and freckle-removing composition comprises a yeast extract and an astaxanthin extract. The invention also provides a preparation method of the whitening and freckle-removing composition, 1) weighing 1-40 parts by weight of yeast extract and 0.01-5 parts by weight of astaxanthin extract, wherein the granularity of the yeast extract and the astaxanthin extract is 80-150 meshes; 2) adding yeast extract and astaxanthin extract into three-dimensional mixer at rotation speed of 10-14rpm for 15-20 min, and mixing. The whitening and freckle-removing composition is used for food or health food, acts on the whole body through oral administration, and inhibits the activity of tyrosinase and the formation of free radicals, so that the skin becomes light and the whitening and freckle-removing effects are achieved. The composition does not contain any cosmetic-grade components, all the components are food raw materials or food additives, and the composition has no toxic or side effect.
Description
Technical Field
The invention belongs to the field of biological medicines, and particularly relates to a whitening and freckle-removing composition and a preparation method thereof.
Background
The pigment substances of the skin include melanin, carotene, etc., and melanin is produced by melanocytes in the skin and is a main factor determining the color of the skin. The synthesis of melanin must involve 3 substances, tyrosine, the main raw material for synthesizing melanin, tyrosinase, the main rate-limiting enzyme for catalyzing the conversion of tyrosine into melanin, and oxygen which participates in the catalytic process.
The skin is the protective barrier of the outermost layer of the human body and is composed of a plurality of layers of tissues, wherein the outermost layer is the horny layer composed of dead horny cells, the horny layer is thick and compact, the invasion of bacteria and harmful chemical substances can be effectively prevented, and the surface of the horny layer is also provided with a lipid film, so that the skin can be smooth and glossy, and the evaporation of water in the body can be prevented. The presence of the stratum corneum and lipid membranes imparts water impermeability to the skin. The natural protective mechanism of human skin allows only a very small amount of water and fat-soluble substances to pass through. Many water-soluble substances in cosmetics, such as vitamin C and macromolecular proteins, cannot penetrate through the stratum corneum or the pilosebaceous glands to be absorbed by the skin. Due to the barrier effect of human skin, substances coated on the skin surface are difficult to absorb, so the external skin whitening product has slow effect and limited effect, and the effect is not systemic, is only local and is limited by time and region in use
Disclosure of Invention
The invention aims to provide a whitening and freckle-removing composition which is used in the field of food or health-care food and can lighten the skin to achieve the effects of whitening and removing freckles.
In addition, a preparation method of the whitening and freckle-removing composition is also provided.
A whitening and speckle removing composition comprises yeast extract and astaxanthin extract.
Preferably, the whitening and freckle-removing composition comprises the following components in parts by weight: 1-40 parts of yeast extract and 0.01-5 parts of astaxanthin extract.
More preferably, the whitening and freckle-removing composition comprises the following components in parts by weight: 25-30 parts of yeast extract and 2-3 parts of astaxanthin extract.
Further preferably, the whitening and freckle-removing composition comprises the following components in parts by weight: 25-30 parts of yeast extract and 2.5 parts of astaxanthin extract.
Preferably, the yeast extract is selected from one or more of yeast fermentation powder, yeast extract and glutathione-rich yeast powder, and more preferably, the yeast is glutathione-rich yeast.
Wherein the astaxanthin extract is haematococcus pluvialis powder.
Wherein the yeast extract is prepared by the following method:
adding yeast into water to prepare yeast suspension with dry matter content of 30-40 wt%, adding papain with addition amount of 0.05-0.1 wt% of yeast, heating to 60-70 deg.C, maintaining for 4-5 hr, inactivating at 90 deg.C for 15min, centrifuging at 3000rpm for 30min, collecting lower layer solid, and drying to obtain yeast extract.
Preferably, the yeast is glutathione-Rich yeast (Rich glutathione yeast).
Preferably, the weight ratio of the reduced glutathione in the yeast extract is more than or equal to 15 percent
Preferably, the particle size of the yeast extract and the astaxanthin extract is 80-150 mesh.
A preparation method for preparing the whitening and freckle-removing composition,
1) weighing 1-40 parts by weight of yeast extract and 0.01-5 parts by weight of astaxanthin extract, wherein the particle sizes of the yeast extract and the astaxanthin extract are 80-150 meshes;
2) adding yeast extract and astaxanthin extract into three-dimensional mixer at rotation speed of 10-14rpm for 15-20 min, and mixing.
Compared with the prior art, the whitening and freckle-removing composition is used for food or health food, acts on the whole body through oral administration, and inhibits the activity of tyrosinase and the formation of free radicals, so that the skin becomes light and the whitening and freckle-removing effects are achieved. The composition does not contain any cosmetic-grade components, all the components are food raw materials or food additives, and the composition has no toxic or side effect.
Detailed Description
The present invention will be described in further detail with reference to specific embodiments in order to make the technical field better understand the scheme of the present invention.
Description of the raw materials
Astaxanthin extract: haematococcus pluvialis powder purchased from bioscience, Spanish Gagnep, Inc., with astaxanthin content of 3 wt%, respectively sieving to obtain 60 mesh, 80 mesh, 100 mesh, 150 mesh and 180-mesh Haematococcus pluvialis powder;
glutathione-Rich yeast (Rich glutaminone yeast): purchased from bio-pharmaceuticals, ltd, golden city, Shandong;
papain: CAS NO 9001-73-4, English name Papain, specification of 10 ten thousand U/g, Shanxi Gaoshang biological medicine Co., Ltd;
the yeast extract is prepared by the following method:
adding glutathione-rich yeast into water to prepare yeast suspension, wherein the dry matter content of the yeast suspension is 35 wt%, adding papain, the adding amount of the papain is 0.05 wt% of the yeast dosage, heating to 60-70 deg.C, maintaining for 4 hr, inactivating at 90 deg.C for 15min, centrifuging at 3000rpm for 30min, collecting the lower layer solid, and drying to obtain yeast extract.
Pulverizing, and sieving to obtain yeast extracts of 60 mesh, 80 mesh, 100 mesh, 150 mesh and 180 mesh.
Example 1
1) Weighing the yeast extract and the haematococcus pluvialis powder according to the weight parts shown in the table 1, wherein the granularity of the yeast extract and the haematococcus pluvialis powder is shown in the table 1;
2) the yeast extract and haematococcus pluvialis powder were put into a three-dimensional mixer at a rotation speed of 12rpm for 17 minutes to allow the two to be uniformly mixed.
Example 2
1) Weighing the yeast extract and the haematococcus pluvialis powder according to the weight parts shown in the table 1, wherein the granularity of the yeast extract and the haematococcus pluvialis powder is shown in the table 1;
2) the yeast extract and haematococcus pluvialis powder are put into a three-dimensional mixer, the rotating speed is 10rpm, the mixing time is 20 minutes, and the two are uniformly mixed.
Example 3
1) Weighing the yeast extract and the haematococcus pluvialis powder according to the weight parts shown in the table 1, wherein the granularity of the yeast extract and the haematococcus pluvialis powder is shown in the table 1;
2) the yeast extract and haematococcus pluvialis powder were put into a three-dimensional mixer at 14rpm for 15 minutes to mix them uniformly.
Comparative example 1
Glutathione: reduced glutathione, purchased from Shandong Zoozhao Biotech Co., Ltd, model JH, CAS No.70-18-8
Comparative example 2
30kg of lycium ruthenicum extract, 2.5 kg of rutin, 100 kg of tea polyphenol, 12.5 kg of glutathione, 50 kg of L-cysteine, 50 kg of ellagic acid, 40 kg of ceramide, 0.16 kg of lycopene, 30kg of vitamin C and 0.5 kg of vitamin E are fully and uniformly stirred.
Comparative example 3
Haematococcus pluvialis powder, manufactured by Sienna Gagnep Biotech Ltd, having an astaxanthin content of 3 wt% and 100 mesh.
Comparative example 4
The yeast extract prepared by the invention is 100 meshes.
Comparative examples 5 to 8
1) Weighing the yeast extract and the haematococcus pluvialis powder according to the weight parts shown in the table 1, wherein the granularity of the yeast extract and the haematococcus pluvialis powder is shown in the table 1;
2) the yeast extract and haematococcus pluvialis powder are put into a three-dimensional mixer, the rotating speed is 10rpm, the mixing time is 20 minutes, and the two are uniformly mixed.
Table 1 formulation table of the examples
Haematococcus pluvialis powder | Haematococcus pluvialis powder particle size | Yeast extract | Particle size of yeast extract | |
Example 1 | 5 parts by weight of | 80 mesh | 40 parts by weight of | 150 mesh |
Example 2 | 2 parts by weight of | 100 mesh | 20 parts by weight of | 100 mesh |
Example 3 | 1 part by weight | 150 mesh | 10 parts by weight | 80 mesh |
Comparative example 5 | 2 parts by weight of | 60 mesh | 20 parts by weight of | 60 mesh |
Comparative example 6 | 2 parts by weight of | 60 mesh | 20 parts by weight of | 180 mesh |
Comparative example 7 | 2 parts by weight of | 180 mesh | 20 parts by weight of | 60 mesh |
Comparative example 8 | 2 parts by weight of | 180 mesh | 20 parts by weight of | 180 mesh |
The compositions obtained in examples 1 to 3 and comparative examples 1 to 8 were sieved with a 60-mesh sieve to obtain capsule contents, and the capsule contents were placed in a hopper of a capsule machine to prepare capsules having a specification of 0.4 g/capsule.
Example 4
(1) Preparing a mixed material: weighing 20kg of yeast extract and 2kg of astaxanthin. Making yeast extract into soft material with 75% ethanol, granulating with swing granulator, sieving with 14 mesh sieve, and drying to obtain granule with water content of about 3.5%. And then uniformly mixing the astaxanthin white particles to obtain a mixed material.
(2) Preparation of tablets: the resulting blend was placed in the hopper of a tablet press to make tablets of 1.0 g/pellet size.
Example 5
(1) Preparing feed liquid: 10kg of yeast extract, 1kg of astaxanthin and 30kg of purified water were weighed. Adding the yeast extract and the astaxanthin into purified water, stirring to completely dissolve the yeast extract and the astaxanthin, and uniformly stirring to obtain a feed liquid.
(2) Preparing oral liquid: the obtained feed liquid is made into oral liquid with the specification of 50 mL/bottle by an oral liquid capping machine.
The obtained capsules prepared in examples 1 to 3 and comparative examples 1 to 8, the tablets prepared in example 4, and the oral liquid prepared in example 5 were subjected to the following whitening effect test.
1. Test samples and dosages:
examples 1-3 and comparative examples 1-8 (2 capsules per day), example 4 (2 tablets per day), example 5 (2 bottles per day), physiological saline (100 mL per day).
2. Selecting a crowd:
age interval: 25-45 years old; sex: 50 men and women respectively; and (3) testing season: 10-12 months
3. The experimental process comprises the following steps:
in each group of experiments, a test subject is selected to be tested, the left arm and the right arm of the test subject are selected to be used as data acquisition areas, technicians use a test instrument to perform initial value data acquisition, and the tested part cannot use any cosmetics during the experiment. Subjects ate the test samples for eight weeks continuously and data is collected periodically during the test period. And (4) carrying out statistical analysis on the acquisition result, carrying out paired t test and calculating the mean value.
Relative initial value change ratio (%) - (Tn-T0)/T0X 100
Relative blank change ratio (%) - (Tn-T0) - (Kn-K0) ]/T0 × 100
In the formula: tn represents the value of the test site
T0 denotes the initial value of the test site
Kn represents blank group number
K0 denotes blank set start value
4. Testing instrument
Skin melanin and heme tester Mexameter MX18 (Germany CK Co.)
5. Test index
The MI value represents the index of melanin, the measuring range of the instrument is 0-999, and the higher the measuring value is, the higher the melanin content in the skin is.
6. The results are shown in Table 2
TABLE 2 values of mean MI over time of the test population
As shown in the results in Table 2, the whitening and freckle-removing composition prepared by the invention is remarkably better than that prepared by singly using haematococcus pluvialis powder and a yeast extract, and has obvious synergistic effect on whitening effect and lasting effect.
Stability test
After the compositions of examples 1 to 5 were exposed to the air for 1 month, the whitening effect test was performed according to the above-mentioned method, and the measured MI values are shown in Table 3
Table 3 whitening efficacy test results (MI value) of the composition after one month exposure to air
1 week | 2 weeks | 3 weeks | 4 weeks | 5 weeks | 6 weeks | 7 weeks | 8 weeks | |
Example 1 | 426 | 416 | 413 | 389 | 365 | 333 | 315 | 309 |
Example 2 | 428 | 417 | 413 | 386 | 363 | 325 | 312 | 308 |
Example 3 | 434 | 418 | 415 | 395 | 368 | 334 | 321 | 311 |
Example 4 | 429 | 420 | 419 | 398 | 374 | 351 | 331 | 315 |
Example 5 | 421 | 413 | 413 | 402 | 379 | 370 | 341 | 331 |
Physiological saline | 415 | 413 | 415 | 417 | 416 | 414 | 416 | 416 |
When the granularity of the haematococcus pluvialis powder and the yeast extract is between 80 and 150 meshes, the whitening composition has better effect, and the whitening and freckle removing composition prepared from the haematococcus pluvialis powder and the yeast extract has good stability when the granularity is uniform.
The previous description of the disclosed embodiments is provided to enable any person skilled in the art to make or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the invention. Thus, the present invention is not intended to be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Claims (9)
1. A whitening and freckle-removing composition is characterized by comprising a yeast extract and an astaxanthin extract.
2. The whitening and freckle-removing composition according to claim 1, which is characterized by comprising the following components in parts by weight: 1-40 parts of yeast extract and 0.01-5 parts of astaxanthin extract.
3. The whitening spot-removing composition of claim 2, wherein:
the yeast extract is selected from one or more than two of yeast fermentation powder, yeast extract and glutathione-rich yeast powder.
4. The whitening spot-removing composition of claim 3, wherein:
the astaxanthin extract is haematococcus pluvialis powder.
5. The whitening spot-removing composition of claim 4, wherein:
the yeast extract is prepared by the following method:
adding yeast into water to prepare yeast suspension with dry matter content of 30-40 wt%, adding papain with addition amount of 0.05-0.1 wt% of yeast, heating to 60-70 deg.C, maintaining for 4-5 hr, inactivating at 90 deg.C for 15min, centrifuging at 3000rpm for 30min, collecting lower layer solid, and drying to obtain yeast extract.
6. The whitening spot-removing composition of claim 5, wherein:
the yeast is glutathione-rich yeast.
7. The whitening spot-removing composition of claim 6, wherein:
the weight ratio of the reduced glutathione in the yeast extract is more than or equal to 15 percent.
8. The whitening spot-removing composition of claim 7, wherein:
the particle size of the yeast extract and the astaxanthin extract is 80-150 meshes.
9. A method for preparing the whitening and spot-removing composition according to any one of claims 1 to 8, which is characterized by comprising the following steps:
1) weighing 1-40 parts by weight of yeast extract and 0.01-5 parts by weight of astaxanthin extract, wherein the particle sizes of the yeast extract and the astaxanthin extract are 80-150 meshes;
2) adding yeast extract and astaxanthin extract into three-dimensional mixer at rotation speed of 10-14rpm for 15-20 min, and mixing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011399632.1A CN112544968A (en) | 2020-12-04 | 2020-12-04 | Whitening and freckle removing composition and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011399632.1A CN112544968A (en) | 2020-12-04 | 2020-12-04 | Whitening and freckle removing composition and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112544968A true CN112544968A (en) | 2021-03-26 |
Family
ID=75048043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011399632.1A Pending CN112544968A (en) | 2020-12-04 | 2020-12-04 | Whitening and freckle removing composition and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112544968A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113115876A (en) * | 2021-04-28 | 2021-07-16 | 北京逯博士行为医学科技研究院有限公司 | Whitening composition for strengthening skin and strengthening body |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1748573A (en) * | 2005-10-10 | 2006-03-22 | 华南理工大学 | Nutritious food containing astaxanthin and its preparation method |
WO2010112071A1 (en) * | 2009-04-01 | 2010-10-07 | Phf S.A. | Combination of astaxanthin, antioxidants and colouring agents with sunscreen effect to be administered orally |
JP2011032171A (en) * | 2009-07-29 | 2011-02-17 | Fuji Chem Ind Co Ltd | Skin whitening composition |
JP2012153636A (en) * | 2011-01-25 | 2012-08-16 | Fuji Chem Ind Co Ltd | Glutathione production enhancer |
CN104757560A (en) * | 2014-08-11 | 2015-07-08 | 四川安益生物科技有限公司 | Glutathione yeast enzymolysis solution composition and preparation method thereof |
CN108813436A (en) * | 2018-07-10 | 2018-11-16 | 曾杨列 | Nutrition fortifier with strengthen immunity and the application in health leisure food |
CN109662231A (en) * | 2019-01-09 | 2019-04-23 | 西安源森生物科技有限公司 | A kind of solid beverage and preparation method thereof with anti-oxidation efficacy |
CN110037257A (en) * | 2019-03-29 | 2019-07-23 | 广东澳思瑞雅健康美容生物科技有限公司 | A kind of formula and preparation method of immunological regulation and enhancing physical strength |
-
2020
- 2020-12-04 CN CN202011399632.1A patent/CN112544968A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1748573A (en) * | 2005-10-10 | 2006-03-22 | 华南理工大学 | Nutritious food containing astaxanthin and its preparation method |
WO2010112071A1 (en) * | 2009-04-01 | 2010-10-07 | Phf S.A. | Combination of astaxanthin, antioxidants and colouring agents with sunscreen effect to be administered orally |
JP2011032171A (en) * | 2009-07-29 | 2011-02-17 | Fuji Chem Ind Co Ltd | Skin whitening composition |
JP2012153636A (en) * | 2011-01-25 | 2012-08-16 | Fuji Chem Ind Co Ltd | Glutathione production enhancer |
CN104757560A (en) * | 2014-08-11 | 2015-07-08 | 四川安益生物科技有限公司 | Glutathione yeast enzymolysis solution composition and preparation method thereof |
CN108813436A (en) * | 2018-07-10 | 2018-11-16 | 曾杨列 | Nutrition fortifier with strengthen immunity and the application in health leisure food |
CN109662231A (en) * | 2019-01-09 | 2019-04-23 | 西安源森生物科技有限公司 | A kind of solid beverage and preparation method thereof with anti-oxidation efficacy |
CN110037257A (en) * | 2019-03-29 | 2019-07-23 | 广东澳思瑞雅健康美容生物科技有限公司 | A kind of formula and preparation method of immunological regulation and enhancing physical strength |
Non-Patent Citations (2)
Title |
---|
刘会平 等: "白藜芦醇-葡萄多酚复方口服液的抗氧化活性和美白作用评价", 《现代食品科技》 * |
黄海: "啤酒废酵母多糖及谷胱甘肽提取工艺的研究", 《中国优秀硕士学位论文全文数据库(电子期刊)》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113115876A (en) * | 2021-04-28 | 2021-07-16 | 北京逯博士行为医学科技研究院有限公司 | Whitening composition for strengthening skin and strengthening body |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101954064B (en) | Composition for whitening and removing spots and preparation method thereof | |
CN108135879B (en) | Hair-growing agent | |
CN111202695A (en) | Natural edible composition with health care function, application thereof, makeup cosmetic and preparation method thereof | |
CN107397697B (en) | Whitening and freckle removing composition and application thereof | |
JP2008280271A (en) | Agent for preventing photoaging of skin | |
JP7643335B2 (en) | Composition containing Almium extract | |
CN110338412A (en) | The composition and its preparation of niacinamide-containing mononucleotide and ice plant and application | |
CN111032009B (en) | Skin whitening agent, external skin preparation for whitening skin, and method for whitening skin | |
CN107308020B (en) | Stable polypeptide composition and application thereof | |
CN115670964B (en) | Preparation method, composition and application of hydrolyzed ginseng saponin composition with soothing and repairing effects | |
CN102885309A (en) | Chloasma removing healthcare food composite and preparation method thereof | |
JP5921056B2 (en) | Cosmetic composition | |
CA2702711A1 (en) | Liquid preparation containing herb and/or animal-origin extract | |
CN111110615A (en) | A kind of matsutake facial mask liquid, its preparation method and application | |
CN112544968A (en) | Whitening and freckle removing composition and preparation method thereof | |
CN105030716B (en) | Caffeinum pharmaceutical combination and preparation method thereof | |
WO2008029877A1 (en) | Anti-aging agent, skin-whitening agent, anti-oxidative agent, and anti-inflammatory agent | |
CN108938482A (en) | Cordyceps sinensis composition, cordyceps sinensis facial mask and preparation method, application | |
CN1794967B (en) | Whitening and antioxidative cosmetic composition containing resveratrol and method for preparing the same | |
CN107669731A (en) | A kind of skin care compositions and its application, health products | |
CN101829042B (en) | Anti-aging Chinese medicinal mask and preparation method thereof | |
CN114948813A (en) | Anti-saccharification and anti-aging natural product composition, preparation method thereof and application thereof in oral beauty products | |
CN112367969A (en) | Antioxidant agent | |
CN105362591A (en) | Pharmaceutical composition and preparation method, preparation and application thereof | |
CN108514529B (en) | Extraction method and application of traditional Chinese medicine extract for whitening cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210326 |
|
RJ01 | Rejection of invention patent application after publication |